Effect of low-dose methylprednisolone on serum TNF-α level in children with Mycoplasma pneumoniae pneumonia

HE Jin-E; GAO Chun-Yan; LI Hong-Ri

doi:10.7499/j.issn.1008-8830.2013.10.010

PDF(1270 KB)

Chinese Journal of Contemporary Pediatrics ›› 2013, Vol. 15 ›› Issue (10) : 850-853. DOI: 10.7499/j.issn.1008-8830.2013.10.010

CLINICAL RESEARCH

Effect of low-dose methylprednisolone on serum TNF-α level in children with Mycoplasma pneumoniae pneumonia

HE Jin-E, GAO Chun-Yan, LI Hong-Ri

Author information +

History +

Abstract

OBJECTIVE: To investigate the effect of low-dose methylprednisolone on serum tumor necrosis factor alpha (TNF-α) level in children with Mycoplasma pneumoniae pneumonia (MPP). METHODS: A case-control study was conducted among 38 children with MPP who received treatment in the Affiliated Hospital of Yan'an University between January and December 2012, and who had not received glucocorticoids before hospitalization. They were randomly divided into methylprednisolone treatment (n=20) and conventional treatment groups (n=18). The methylprednisolone treatment group was administered with methylprednisolone (1 mg/kg·d) by intravenous drip for three days in addition to conventional treatment. Serum samples were collected from both groups before treatment and on days 4 and 7 of treatment. Twenty-five children who underwent physical examination in the healthcare clinic during the same period were randomly selected as a normal control group, and serum samples were collected on the same day that the physical examination was performed. Serum TNF-α levels in the three groups were measured using enzyme-linked immunosorbent assay. RESULTS: On admission, the methylprednisolone treatment and conventional treatment groups had significantly higher serum TNF-α levels than the normal control group (P<0.01), but there was no significant difference between the methylprednisolone treatment and conventional treatment groups. On days 4 and 7 of treatment, the methylprednisolone treatment group had significantly lower serum TNF-α levels than the conventional treatment group (P<0.05; P<0.01). On day 7 of treatment, there was no significant difference in serum TNF-α level between the methylprednisolone treatment and normal control groups, but the conventional treatment group still had a significantly higher serum TNF-α level than the normal control group (P<0.01). CONCLUSIONS: Low-dose methylprednisolone can significantly decrease serum TNF-α level and inhibit inflammatory response in children with MPP, and may reduce damage caused by inflammatory response.

Key words

Mycoplasma pneumoniae pneumonia / Tumor necrosis factor alpha / Methylprednisolone / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

HE Jin-E, GAO Chun-Yan, LI Hong-Ri. Effect of low-dose methylprednisolone on serum TNF-α level in children with Mycoplasma pneumoniae pneumonia[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(10): 850-853 https://doi.org/10.7499/j.issn.1008-8830.2013.10.010

References

[1] Ngeow YF, Suwanjutha S, Chantarojanasfifi T, Wang F, Saniel M, Alejandria M, et al. An Asian study on the prevalence of a typical respiratory pathogens in community-acquired pneumonia[J]. Int J Infect Dis, 2005, 9(3): 144-153.

[2] Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children[J]. Korean J Pediatr, 2012, 55(2): 42-47.

[3] Vervloet LA, Vervloet VE, Tironi Junior M, Ribeiro JD. Mycoplasma pneumoniae-related community-acquired pneumonia and parapneumonic pleural effusion in children and adolescents[J]. J Bras Pneumol, 2012, 38(2): 226-236.

[4] Ahn KK, Kwon D, Jung K, Ha Y, Seo MJ, Kim SH, et al. Identification of interleukin-1, tumor necrosis factor-alpha, and interleukin-6 expression in lungs from pigs naturally infected with Mycoplasma hyopneumoniae by in situ hybridization[J]. J Vet Med Sci, 2009, 71(4): 441-445.

[5] Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNF-alpha in pulmonary pathophysiology[J]. Respir Res, 2006, 7(125): 1-9.

[6] Baluk P, Yao LC, Feng J, Romano T, Jung SS, Schreiter JL, et al. TNF-α drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice[J]. Clin Invest, 2009, 119(10): 2954-2964.

[7] Fernaders AB, Zin WA, Rocco PR. Corticosteroids in acute respiratory distress syndrome[J]. Braz J Med Biol Res, 2005, 38(2): 147-159.

[8] Morrow MD. Implications of pharmacogenomics in the current and future treatment of asthma[J]. J Manag Care Pharm, 2007, 13(6): 497-505.

[9] Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome[J]. N Engl J Med, 2006, 354(16): 1671-1684.

[10] 申昆玲, 江载芳. 支原体肺炎[M] //胡亚美, 江载芳. 诸福棠实用儿科学上册. 第7版. 北京: 人民卫生出版社, 2002: 1204-1205.

[11] 曹岩, 刘红, 卢晟晔, 杨春荣. 儿童肺炎支原体肺炎血清中TNF-α、IL-6、IL-8和IL-10浓度测定及其临床意义的研究[J]. 中国妇幼保健, 2008, 23(18): 2575-2578.

[12] 郦银芳, 于莹, 陆志芳. IL-13和TNF-α在肺炎支原体肺炎儿童血清中的表达及意义[J].中国当代儿科杂志, 2010, 12(4): 275-277.

[13] 庞焕香, 乔红梅, 成焕吉, 张云峰, 刘肖君, 李君召. 支原体肺炎患儿肺泡灌洗液中TNF-α、IL-6、IL-10水平检测及意义[J]. 中国当代儿科杂志, 2011, 13(10): 808-810.

[14] Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome[J]. Chest, 1987, 92(6): 1032-1036.

[15] Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial[J]. Chest, 2007, 131(4): 954-963.

[16] Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome[J]. Ann Thorac Surg, 2005, 79(2): 405-410.

[17] 李红日, 宋国维, 甘小庄, 崔小岱, 孙春荣, 孙丽萍. 小剂量氢化可的松对急性肺损伤大鼠血清炎性因子的影响[J]. 实用儿科临床杂志, 2008, 23(6): 412-414.

[18] 丁圣刚, 王建, 王亚亭, 丁俊丽. 糖皮质激素在治疗儿童重症肺炎支原体肺炎（MPP）中的价值[J]. 复旦学报（医学版）, 2012, 39(2): 180-183.

[19] Remmelts HH, Meijvis SC, Biesma DH, van Velzen-Blad H, Voorn GP, Grutters JC, et al. Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia[J]. Clin Vaccine Immunol, 2012, 19(9): 1532-1538.